Drug Utilisation Sub-Committee (DUSC) utilisation analysis of medicines for type 2 diabetes

The utilisation analysis Public Release Document for the review of medicines for the treatment of type 2 diabetes from the September 2022 Drug Utilisation Sub-Committee meeting is now available.